Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PT Itama Ranoraya Tbk's Enterprise Value is Rp1,439,542 Mil.
PT Itama Ranoraya Tbk's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was Rp116,504 Mil. Therefore, PT Itama Ranoraya Tbk's EV-to-EBIT ratio for today is 12.36.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, PT Itama Ranoraya Tbk's Enterprise Value is Rp1,439,542 Mil.
PT Itama Ranoraya Tbk's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was Rp131,373 Mil. Therefore, PT Itama Ranoraya Tbk's EV-to-EBITDA ratio for today is 10.96.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, PT Itama Ranoraya Tbk's Enterprise Value is Rp1,439,542 Mil.
PT Itama Ranoraya Tbk's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was Rp1,102,987 Mil. Therefore, PT Itama Ranoraya Tbk's EV-to-Revenue ratio for today is 1.31.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
PT Itama Ranoraya Tbk (ISX:IRRA) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
PT Itama Ranoraya Tbk's current Enterprise Value is Rp1,439,542 Mil.
PT Itama Ranoraya Tbk's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp116,504 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
PT Itama Ranoraya Tbk's EV-to-EBITDA for today is:
PT Itama Ranoraya Tbk's current Enterprise Value is Rp1,439,542 Mil.
PT Itama Ranoraya Tbk's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp131,373 Mil.
PT Itama Ranoraya Tbk's current Enterprise Value is Rp1,439,542 Mil.
PT Itama Ranoraya Tbk's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp1,102,987 Mil.
PT Itama Ranoraya Tbk's current Enterprise Value is Rp1,439,542 Mil.
PT Itama Ranoraya Tbk's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-326,958 Mil.
PT Itama Ranoraya Tbk's current Enterprise Value is Rp1,439,542 Mil.
PT Itama Ranoraya Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-371,119 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Itama Ranoraya Tbk Enterprise Value Related Terms
PT Itama Ranoraya Tbk Enterprise Value Historical Data
* Premium members only.
The historical data trend for PT Itama Ranoraya Tbk's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:IRRA vs MCK, CAH, COR: Enterprise Value Comparison
For the Medical Distribution subindustry, PT Itama Ranoraya Tbk's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Itama Ranoraya Tbk Enterprise Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Itama Ranoraya Tbk's Enterprise Value distribution charts can be found below:
* The bar in red indicates where PT Itama Ranoraya Tbk's Enterprise Value falls into.
PT Itama Ranoraya Tbk Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
PT Itama Ranoraya Tbk's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of Rp1,439,542 Mil mean?
PT Itama Ranoraya Tbk (ISX:IRRA) has a Enterprise Value of Rp1,439,542 Mil as of Jul. 04, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on PT Itama Ranoraya Tbk and its competitors.
Is PT Itama Ranoraya Tbk's Enterprise Value too high?
PT Itama Ranoraya Tbk's current Enterprise Value is Rp1,439,542 Mil. Overall, PT Itama Ranoraya Tbk has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Itama Ranoraya Tbk's Enterprise Value compare to MCK and CAH?
PT Itama Ranoraya Tbk's Enterprise Value of Rp1,439,542 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Distribution company?
A good Enterprise Value depends on the Medical Distribution industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on PT Itama Ranoraya Tbk and its competitors. PT Itama Ranoraya Tbk's current Enterprise Value is Rp1,439,542 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Itama Ranoraya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk (ISX:IRRA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp535.69, compared to a current price of Rp374.00 — trading 30.2% below its estimated fair value. The current Enterprise Value is Rp1,439,542 Mil. PT Itama Ranoraya Tbk's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For PT Itama Ranoraya Tbk (ISX:IRRA), the current Enterprise Value is Rp1,439,542 Mil as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Itama Ranoraya Tbk (ISX:IRRA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk stock appears to be undervalued.
The current stock price of Rp374.00 is trading 30.2% below its estimated GF Value™ of Rp535.69.
GuruFocus considers PT Itama Ranoraya Tbk to be Possible Value Trap.
Key valuation signals for ISX:IRRA:
Enterprise Value: Rp1,439,542 Mil
GF Value™: Rp535.69 vs. price of Rp374.00 (30.2% below fair value)
No single metric tells the full story. See the ISX:IRRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Itama Ranoraya Tbk focuses on the trade and distribution of medical devices. The company distributes medical devices such as Oneject auto disable syringe, Abbott diagnostics, TerumoBCT, Ortho Clinical diagnostics and others. It business segment includes Vitro Diagnostic Products, Non-Electromedical Sterile Medical Devices, Electromedical Sterile Medical Devices and Other Segments. The key revenue generating segments of the company are In Vitro Diagnostic product.
81GF Score
Get the complete analysis for ISX:IRRA
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:IRRA has been successfully added to your 
